BSTZ: How To Buy Anthropic With A Discount

BlackRock Science and Technology Term Trust offers pre-IPO exposure to high-profile tech firms like Anthropic. BSTZ focuses on total return and income, targeting long-term capital appreciation in U.S. and non-U.S. science and technology equities. As a closed-end fund, BSTZ trades at a discount or premium to NAV (currently a discount), thus creating potential for additional returns if the discount narrows.

Seeking Alpha • Jun 10, 2026

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

Business Wire • May 29, 2026

The venture fund paying 8% yield while quietly liquidating in five years

The BlackRock Science and Technology Term Trust (NYSE:BSTZ) is an unusual tech vehicle: a closed-end fund with a 2031 liquidation date, an expense ratio near 1.4%, and over 30% of its portfolio invested in private, pre-IPO companies.

24/7 Wall Street • May 5, 2026

This 7.8% Dividend Is A Top Contrarian Play On The Software Crash

The time has come to make a move on this software-stock selloff. And we're going to use our favorite income plays—closed-end funds (CEFs)—to do it.

Forbes • May 2, 2026

BlackRock's BSTZ Expires in 2031 and Forces a Reckoning: What Happens to Your Pre-IPO Positions

BlackRock Science & Technology Term Trust (NYSE:BSTZ) is a closed-end fund with a fixed expiration date, a covered call overlay, and more than 30% of its portfolio locked in private, pre-IPO companies that most investors cannot access through a brokerage account.

24/7 Wall Street • Apr 21, 2026

This ‘Boring' Fund Owns The Hottest AI Firm On Earth, Yields 8.3%

AI is making real money—I'm talking about $30 billion in revenue for just one leading AI firm.

Forbes • Apr 18, 2026

Saba Capital's $93.8 Million Bet Signals Trouble Brewing at BSTZ

BlackRock Science and Technology Term Trust (NYSE:BSTZ) has attracted income-focused investors with a yield that has ranged between 8% and 12% depending on when you bought it.

24/7 Wall Street • Apr 15, 2026

Why BSTZ's 8% Yield Masks a Fragile Income Engine Built on Private Bets

BlackRock Science and Technology Term Trust (NYSE:BSTZ) has gained 57.79% over the past year, with shares recently touching $23.92.

24/7 Wall Street • Apr 14, 2026

Why retirees are buying this closed-end fund yielding 8% on venture-stage tech

BlackRock Science & Technology Term Trust (NYSE:BSTZ) is a closed-end fund (CEF) that combines a venture-stage technology portfolio with a covered call writing strategy to deliver monthly income.

24/7 Wall Street • Apr 14, 2026

BSTZ: Getting Off Mr. Toad's Wild Ride (Rating Downgrade)

BSTZ has dramatically shifted its portfolio, now heavily concentrated in private, illiquid technology and AI investments. BSTZ's private assets, including Anthropic at 15% of holdings, now comprise nearly half the portfolio, heightening liquidity and valuation risks. Distribution and management changes, along with increased private exposure, have altered BSTZ's risk profile and diverged from its original mandate.

Seeking Alpha • Apr 14, 2026